Ely Benaim, Chief Medical Officer at NovoCure Ltd (NVCR), sold 4,968 shares at $156.71 ($779K) on 2020-12-21, disclosed to the SEC on 2020-12-22.
Open-market sale of $779k NVCR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $156.71 | 651 | $102K | 13.1% |
| 2 | $156.71 | 651 | $102K | 13.1% |
| 3 | $156.71 | 1,833 | $287K | 36.9% |
| 4 | $156.71 | 1,833 | $287K | 36.9% |
| Total | $156.71 avg | 4,968 | $779K | 100% |
| Filing → |
| NVCR | SELL | 2022-05-12 | $531K | — | Filing → |
| NVCR | SELL | 2022-03-07 | $332K | — | Filing → |
| NVCR | SELL | 2021-08-04 | $139K | — | Filing → |